These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6357591)

  • 41. Comparison of clinic and home blood pressure levels and the role of the sympathetic nervous system in clinic-home differences.
    Saito I; Takeshita E; Hayashi S; Takenaka T; Murakami M; Saruta T; Nagano S; Sekihara T
    Am J Hypertens; 1990 Mar; 3(3):219-24. PubMed ID: 2322433
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of L-dopa in young patients with hypertension.
    Saito I; Kawabe H; Hasegawa C; Iwaida Y; Yamakawa H; Saruta T; Takeshita E; Nagano S; Sekihara T
    Angiology; 1991 Sep; 42(9):691-5. PubMed ID: 1928809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-dependent suppression of norepinephrine appearance rate in plasma by clonidine in man.
    Veith RC; Best JD; Halter JB
    J Clin Endocrinol Metab; 1984 Jul; 59(1):151-5. PubMed ID: 6725520
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasma clonidine in relation to blood pressure, catecholamines, and renin activity during long-term treatment of hypertension.
    Manhem P; Paalzow L; Hökfelt B
    Clin Pharmacol Ther; 1982 Apr; 31(4):445-51. PubMed ID: 7037264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Clonidine-diuretic combination in patients with essential hypertension. Modification of sympathetic activity and blood pressure as well as the reaction following sudden withdrawal].
    Beckenbauer UE; Planz G
    Fortschr Med; 1984 Aug; 102(31-32):802-6. PubMed ID: 6479820
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Changes in blood pressure, plasma catecholamines and plasma renin activity during and after treatment with tiamenidine and clonidine.
    Hansson BG; Hökfelt B
    Br J Clin Pharmacol; 1981 Jan; 11(1):73-7. PubMed ID: 7011348
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Captopril in essential hypertension; contrasting effects of adding hydrochlorothiazide or propranolol.
    MacGregor GA; Markandu ND; Banks RA; Bayliss J; Roulston JE; Jones JC
    Br Med J (Clin Res Ed); 1982 Mar; 284(6317):693-6. PubMed ID: 6802291
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clonidine and guanfacine in hypertension.
    Jain AK; Hiremath A; Michael R; Ryan JR; McMahon FG
    Clin Pharmacol Ther; 1985 Mar; 37(3):271-6. PubMed ID: 3882307
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Timolol and a hydrochlorothiazide-amiloride combination in the treatment of essential hypertension in young and middle-aged patients: a comparative study with once-daily administration.
    Lindroos M; Lehtonen A
    Int J Clin Pharmacol Ther Toxicol; 1984 Dec; 22(12):643-5. PubMed ID: 6396239
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Verapamil versus hydrochlorothiazide in the treatment of hypertension: results of long term double blind comparative trial. Verapamil versus Diuretic (VERDI) Trial Research Group.
    Holzgreve H; Distler A; Michaelis J; Philipp T; Wellek S
    BMJ; 1989 Oct; 299(6704):881-6. PubMed ID: 2510877
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term haemodynamic effects of enalapril (alone and in combination with hydrochlorothiazide) at rest and during exercise in essential hypertension.
    Lund-Johansen P; Omvik P
    J Hypertens Suppl; 1984 Dec; 2(2):S49-56. PubMed ID: 6100877
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nonnarcotic antidiarrheal action of clonidine and lofexidine in the rat.
    Lal H; Shearman GT; Ursillo RC
    J Clin Pharmacol; 1981 Jan; 21(1):16-9. PubMed ID: 7217339
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A preliminary evaluation of the effect of lofexidine on vasomotor flushes in post-menopausal women.
    Jones KP; Ravnikar V; Schiff I
    Maturitas; 1985 Jul; 7(2):135-9. PubMed ID: 4033447
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lofexidine for opioid detoxification.
    Thomas M; Jose SM
    Psychiatry (Edgmont); 2005 Jan; 2(1):19. PubMed ID: 21179638
    [No Abstract]   [Full Text] [Related]  

  • 55. A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms.
    Urits I; Patel A; Zusman R; Virgen CG; Mousa M; Berger AA; Kassem H; Jung JW; Hasoon J; Kaye AD; Viswanath O
    Psychopharmacol Bull; 2020 Jul; 50(3):76-96. PubMed ID: 32733113
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hemodynamic effect of lofexidine with a diuretic in hypertension.
    Vlachakis ND; Velasquez M; Alexander N; Maronde RF
    Clin Pharmacol Ther; 1983 Dec; 34(6):764-9. PubMed ID: 6357591
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lofexidine and clonidine in moderate essential hypertension.
    Wilkins LH; Winternitz SR; Oparil S; Smith LR; Dustan HP
    Clin Pharmacol Ther; 1981 Dec; 30(6):752-07. PubMed ID: 7030578
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Medroxalol combined with hydrochlorothiazide in the treatment of hypertension.
    Vlachakis ND; Valasquez M; Alexander N; Maronde RF
    J Clin Pharmacol; 1983 Oct; 23(10):419-27. PubMed ID: 6139390
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Comparative efficacy and safety of lofexidine and clonidine in mild to moderately severe systemic hypertension.
    Lopez LM; Mehta JL
    Am J Cardiol; 1984 Mar; 53(6):787-90. PubMed ID: 6702628
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Centrally acting antihypertensive agents: a comparison of lofexidine with clonidine.
    Schultz HS; Chretien SD; Brewer DD; Eltorai MI; Weber MA
    J Clin Pharmacol; 1981; 21(2):65-71. PubMed ID: 7229119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.